| Year |
Citation |
Score |
| 2020 |
Chen S, Wang Q, Yu H, Capitano ML, Vemula S, Nabinger SC, Gao R, Yao C, Kobayashi M, Geng Z, Fahey A, Henley D, Liu SZ, Barajas S, Cai W, ... ... Wong TN, et al. Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway. Nature Communications. 11: 3856. PMID 32724180 DOI: 10.1038/S41467-020-17555-0 |
0.473 |
|
| 2019 |
Chen S, Wang Q, Yu H, Capitano ML, Vemula S, Nabinger SC, Gao R, Yao C, Kobayashi M, Geng Z, Fahey A, Henley D, Liu SZ, Barajas S, Cai W, ... ... Wong TN, et al. Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway. Nature Communications. 10: 5649. PMID 31827082 DOI: 10.1038/S41467-019-13542-2 |
0.563 |
|
| 2019 |
Berrien-Elliott MM, Sun Y, Neal C, Ireland A, Trissal MC, Sullivan RP, Wagner JA, Leong JW, Wong P, Mah-Som AY, Wong TN, Schappe T, Keppel CR, Cortez VS, Stamatiades EG, et al. MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells. Immunity. PMID 31402259 DOI: 10.1016/J.Immuni.2019.06.016 |
0.554 |
|
| 2018 |
Trissal MC, Wong TN, Yao JC, Ramaswamy R, Kuo I, Baty JD, Sun Y, Jih G, Parikh N, Berrien-Elliott MM, Fehniger TA, Ley TJ, Maillard I, Reddy P, Link DC. MIR142 loss-of-function mutations derepress ASH1L to increase HOXA gene expression and promote leukemogenesis. Cancer Research. PMID 29724719 DOI: 10.1158/0008-5472.Can-17-3592 |
0.662 |
|
| 2018 |
Wong TN, Miller CA, Jotte MRM, Bagegni N, Baty JD, Schmidt AP, Cashen AF, Duncavage EJ, Helton NM, Fiala M, Fulton RS, Heath SE, Janke M, Luber K, Westervelt P, et al. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential. Nature Communications. 9: 455. PMID 29386642 DOI: 10.1038/S41467-018-02858-0 |
0.648 |
|
| 2017 |
Wong TN, Link DC. miR-125b promotes leukemogenesis via VEGFA. Blood. 129: 1409-1410. PMID 28302689 DOI: 10.1182/Blood-2017-01-761544 |
0.539 |
|
| 2017 |
Wong TN, Miller CA, Jotte MR, Bagegni N, Baty JD, Schmidt AE, Cashen AF, Duncavage EJ, Helton NM, Fiala MA, Fulton RS, Heath SE, Janke M, Luber K, Westervelt P, et al. Cellular Stressors Contribute to the Expansion of Multiple Hematopoietic Clones of Varying Leukemic Potential Blood. 130: 469-469. DOI: 10.1182/Blood.V130.Suppl_1.469.469 |
0.481 |
|
| 2017 |
Yao J, Wong TN, Trissal M, Ramaswamy R, Sun Y, Reddy PR, Link DC. Abstract 3042:MIR142loss-of-function mutations promote leukemogenesis through derepression ofASH1Lresulting in increasedHOXgene expression Cancer Research. 77: 3042-3042. DOI: 10.1158/1538-7445.Am2017-3042 |
0.602 |
|
| 2016 |
Yao J, Wong TN, Trissal M, Ramaswamy R, Sun Y, Ley TJ, Reddy PR, Link DC. MIR142 Loss-of-Function Mutations Promote Leukemogenesis through Derepression of ASH1L Resulting in Increased HOX Gene Expression Blood. 128: 2718-2718. DOI: 10.1182/Blood.V128.22.2718.2718 |
0.673 |
|
| 2015 |
Wong TN, Miller CA, Klco JM, Petti A, Demeter R, Helton NM, Li T, Fulton RS, Heath SE, Mardis ER, Westervelt P, DiPersio JF, Walter MJ, Welch JS, Graubert TA, et al. Rapid expansion of pre-existing non-leukemic hematopoietic clones frequently follows induction therapy for de novo AML. Blood. PMID 26631115 DOI: 10.1182/Blood-2015-10-677021 |
0.638 |
|
| 2015 |
Young AL, Wong TN, Hughes AE, Heath SE, Ley TJ, Link DC, Druley TE. Quantifying ultra-rare pre-leukemic clones via targeted error-corrected sequencing. Leukemia. 29: 1608-11. PMID 25644247 DOI: 10.1038/Leu.2015.17 |
0.614 |
|
| 2015 |
Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS, Lamprecht TL, Shen D, Hundal J, Fulton RS, Heath S, Baty JD, Klco JM, Ding L, Mardis ER, et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature. 518: 552-5. PMID 25487151 DOI: 10.1038/Nature13968 |
0.638 |
|
| 2015 |
Wong TN, Klco JM, Demeter R, Miller CA, Petti A, Havey N, Fulton R, Heath S, Mardis ER, Westervelt P, DiPersio JF, Walter MJ, Welch JS, Graubert T, Wilson RK, et al. Non-Malignant Oligoclonal Hematopoiesis Commonly Follows Cytoreductive Chemotherapy in Adult De Novo AML Patients Blood. 126: 686-686. DOI: 10.1182/Blood.V126.23.686.686 |
0.648 |
|
| 2015 |
Yao J, Wong TN, Trissal M, Sun Y, Ley TJ, Reddy P, Link DC. Loss-of-Function Mutations of MIR142 May Contribute to Leukemogenesis By Expanding the Pool of Myeloid-Biased HSCs Blood. 126: 1254-1254. DOI: 10.1182/Blood.V126.23.1254.1254 |
0.671 |
|
| 2014 |
Young A, Wong TN, Ley TJ, Link DC, Druley TE. Rare Hematopoietic Subclones Harboring Leukemogenic TP53 Mutations Are Detectable Via Error-Corrected Sequencing in Healthy Elderly Individuals Blood. 124: 2907-2907. DOI: 10.1182/Blood.V124.21.2907.2907 |
0.645 |
|
| 2009 |
Wong TN, Pan T. RNA folding during transcription: protocols and studies Methods in Enzymology. 468: 167-193. PMID 20946770 DOI: 10.1016/S0076-6879(09)68009-5 |
0.416 |
|
| 2007 |
Wong TN, Sosnick TR, Pan T. Folding of noncoding RNAs during transcription facilitated by pausing-induced nonnative structures. Proceedings of the National Academy of Sciences of the United States of America. 104: 17995-8000. PMID 17986617 DOI: 10.1073/Pnas.0705038104 |
0.413 |
|
| 2006 |
Wei Y, Liu Y, Wong T, Lemal DM. Extremely facile ring inversion and rearrangement in fluorobicyclo[2.1.0]pentanes Journal of Fluorine Chemistry. 127: 688-703. DOI: 10.1016/J.Jfluchem.2005.12.029 |
0.486 |
|
| 2005 |
Wong T, Sosnick TR, Pan T. Mechanistic insights on the folding of a large ribozyme during transcription. Biochemistry. 44: 7535-42. PMID 15895996 DOI: 10.1021/Bi047560L |
0.42 |
|
| Show low-probability matches. |